Read More

Eiger BioPharmaceuticals Files For Voluntary Chapter 11 Protection; Announces “Stalking Horse” Agreement For The Sale Of Zokinvy To Sentynl Therapeutics For Up To $26M; Access To Zokinvy To Continue Uninterrupted

Announces "Stalking Horse" Agreement for the Sale of Zokinvy® (lonafarnib)Patient Access to Zokinvy® to Continue UninterruptedPALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger BioPharmaceuticals, Inc.

EIGR